Author details

Full Name

Yunguan Wang

Affiliation

ORCID

Career Start Year

2017

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37501682	Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor-positive Breast Cancers for Targeted Treatment.	Cancer Res Commun	2023
38030789	UBE2J1 is the E2 ubiquitin-conjugating enzyme regulating androgen receptor degradation and antiandrogen resistance.		2023
37662218	Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark.		2023
37961351	ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers.	bioRxiv	2023
37478850	Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer.	Cancer Cell	2023
36993727	Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease.	bioRxiv	2023
37040760	Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease.	Cell	2023
37503303	Perturbations of glutathione and sphingosine metabolites in Port Wine Birthmark patient-derived induced pluripotent stem cells.		2023
37502925	Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.	Res Sq	2023
36323264	Arid1a loss potentiates pancreatic Î²-cell regeneration through activation of EGF signaling.	Cell Reports	2022
36241729	Author Correction: Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance.	Nat Cancer	2022
36303017	Netie: inferring the evolution of neoantigen-T cell interactions in tumors.	Nat Methods	2022
36207580	A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.	Commun Biol	2022
36065066	Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance.	Nat Cancer	2022
35927477	Sprod for de-noising spatially resolved transcriptomics data based on position and image information.	Nat Methods	2022
32770205	Spatial molecular profiling: platforms, applications and analysis tools.	Brief Bioinform	2021
36003885	Deep learning-based prediction of the T cell receptor-antigen binding specificity.	Nat Mach Intell	2021
33632817	Liver homeostasis is maintained by midlobular zone 2 hepatocytes.	Science	2021
33406427	Overcoming Expressional Drop-outs in Lineage Reconstruction from Single-Cell RNA-Sequencing Data.	Cell Rep	2021
33167785	Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.	Therapeutic Advances in Respiratory Disease	2020
32908981	The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2.	bioRxiv	2020
31022195	Single cell RNA sequencing reveals regional heterogeneity of hepatobiliary innate lymphoid cells in a tissue-enriched fashion.	PLoS One	2019
30547437	Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.	Methods in Molecular Biology	2019
29874824	Changing Trends in Computational Drug Repositioning.	Pharmaceuticals	2018
30596133	Spatial distribution of marker gene activity in the mouse lung during alveolarization.	Data Brief	2018
28239659	Hsp90 regulation of fibroblast activation in pulmonary fibrosis.	JCI insight	2017
29254233	A core program of gene expression characterizes cancer metastases.	Oncotarget	2017
29058630	Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers.	BMC Pulm Med	2017